Characteristics of cervical cancer patients with SCC and AC
| Parameters | AC | SCC |
|---|---|---|
| Age (yrs) | 52(32–83) | 54(26–83) |
| Grade High Intermediate | 22(63%) 12(34%) | 22(63%) 11(31%) |
| FIGO Stage Stage I Stage II Stage III | 3(9%) 28(80%) 4(11%) | 3(9%) 28(80%) 4(11%) |
| Para-aortic LN Yes No | 2(6%) 33(94%) | 4(11%) 31(89%) |
| Pelvic LN Yes No | 17(49%) 18(51%) | 23(66%) 12(34%) |
| Chemo therapy Cisplatin No chemo Carboplatin | 31(89%) 3(8%) 1(3%) | 29(83%) 6(17%) |
| Mean % reduction at 4wk | 70% | 80% |
| Response at 3 months PR CR PD | 19(54%) 16(46%) 0 | 5(14%) 28(80%) 2(6%) |